GSK plc (GSK.L) Monday said its investigational drug in chronic hepatitis B bepirovirsen received Fast Track designation from the US Food and Drug Administration (FDA).
The designation was supported by data from the phase IIb trials B-Clear and B-Sure, which evaluated the efficacy, safety and durability of response of bepirovirsen in people with chronic hepatitis B.
A confirmatory Phase 3 study of bepirovirsen dubbed B-Well, is ongoing.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.